Potential mechanisms behind (-)-epigallocatechin-3-gallate protection against cerebral ischemic injury.
Amirhossein
A
Sahebkar
D000818:Animals; D002545:Brain Ischemia / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology
D018696:Neuroprotective Agents; D002392:Catechin; C045651:epigallocatechin gallate